GRAIL vs Veeva Systems

Side-by-side comparison of AI visibility scores, market position, and capabilities

Veeva Systems leads in AI visibility (99 vs 39)
GRAIL logo

GRAIL

GrowthHealthcare

Liquid Biopsy Cancer Detection

GRAIL develops multi-cancer early detection Galleri test using cell-free DNA methylation to detect signals from 50+ cancer types in a single blood draw; spun off from Illumina in 2024; NHS-Galleri trial enrolling 140,000 participants in the UK.

AI VisibilityBeta
Overall Score
D39
Category Rank
#1 of 1
AI Consensus
68%
Trend
up
Per Platform
ChatGPT
37
Perplexity
43
Gemini
43

About

GRAIL is a healthcare company founded in 2016 as an Illumina spinout focused on developing multi-cancer early detection tests using liquid biopsy technology. The company's flagship product Galleri is a blood test that analyzes cell-free DNA methylation patterns to detect cancer signals from over 50 cancer types, many of which lack standard screening tests, enabling detection at early stages when treatment is most effective. GRAIL raised over $3.5B from investors including Amazon and Bristol Myers Squibb and was reacquired by Illumina in 2021 before being spun off again in 2024 as an independent public company following regulatory complications. Galleri has been launched commercially and is being evaluated in large clinical studies including the NHS-Galleri trial in the UK enrolling 140,000 participants. The company represents a transformative approach to oncology that could shift cancer care from reactive treatment toward proactive screening. GRAIL's technology addresses a massive unmet need given that the majority of cancers are diagnosed at late stages when outcomes are poor.

Full profile
Veeva Systems logo

Veeva Systems

LeaderHealthcare Tech

Life Sciences Cloud

Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.

AI VisibilityBeta
Overall Score
A99
Category Rank
#1 of 1
AI Consensus
93%
Trend
up
Per Platform
ChatGPT
99
Perplexity
99
Gemini
99

About

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.

Full profile

AI Visibility Head-to-Head

39
Overall Score
99
#1
Category Rank
#1
68
AI Consensus
93
up
Trend
up
37
ChatGPT
99
43
Perplexity
99
43
Gemini
99
39
Claude
97
30
Grok
97

Key Details

Category
Liquid Biopsy Cancer Detection
Life Sciences Cloud
Tier
Growth
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only GRAIL
Liquid Biopsy Cancer Detection
Only Veeva Systems
Life Sciences Cloud

Integrations

Only Veeva Systems
Veeva Systems is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.